Aleksandar Višnjevac

Aleksandar Višnjevac is a Senior Research Associate at the Ruđer Bošković Institute in Zagreb, Croatia, working within the Division of Physical Chemistry, specifically in the Laboratory for chemical and biological crystallography. His research primarily focuses on crystallographic studies of metal complexes with potential pharmaceutical applications, particularly in the areas of anticancer and antidiabetic drug development.

His research interests span crystallography, bioinorganic chemistry, supramolecular chemistry, and pharmaceutical chemistry. Dr. Višnjevac specializes in the structural characterization of metal complexes, particularly those involving zinc, copper, cadmium, and vanadium, with hydrazone-based ligands. His work often explores the relationship between molecular structure and biological activity, with emphasis on DNA/RNA binding, protein interactions, and therapeutic potential. He frequently employs X-ray crystallography alongside computational methods and spectroscopic techniques to understand the structural basis of molecular recognition in biomimetic systems.

Analysis of his recent publications reveals a strong focus on developing metal-based therapeutics, particularly zinc and copper complexes with thiazolyl-hydrazones showing promising anticancer properties, and vanadium complexes demonstrating antidiabetic potential. His work on calixarene derivatives as molecular sensors for nucleotides represents significant contributions to supramolecular chemistry and molecular recognition.

Dr. Višnjevac has been actively involved in educational and outreach projects through the Croatian Association of Crystallographers, contributing to crystallography education and promoting scientific communication. His laboratory serves as a hub for collaborative research involving multiple institutions across Europe, focusing on the intersection of inorganic chemistry, structural biology, and pharmaceutical development.